Doucette Stefani, Tierney Anne, Roggensack Anne, Yusuf Kamran
Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Canada.
Section of Neonatology, Department of Pediatrics, University of Calgary, Cumming School of Medicine, Alberta, Canada.
AJP Rep. 2018 Apr;8(2):e85-e88. doi: 10.1055/s-0038-1645879. Epub 2018 May 4.
Neonatal hyperthyroidism is rare disorder due to the passage of thyroid receptor antibodies (TRBs) from the mother to the fetus. Neonatal thyrotoxicosis can present in several ways and if unrecognized, can be fatal. We present a preterm neonate who developed fetal hydrops and tricuspid regurgitation in utero. The mother had a history of treated Grave's disease. The infant responded to maternal treatment antenatally and postnatal anti-thyroid treatment, with resolution of both the tricuspid regurgitation and hydrops. To our knowledge, this is the first case report of tricuspid regurgitation associated with fetal and neonatal thyrotoxicosis. Our case also highlights the importance of obtaining a detailed and accurate history in a mother with previous Grave's disease, even if treated.
新生儿甲状腺功能亢进症是一种罕见的疾病,是由于甲状腺受体抗体(TRBs)从母亲传给胎儿所致。新生儿甲状腺毒症可通过多种方式表现出来,如果未被识别,可能会致命。我们报告一例早产新生儿,其在子宫内出现胎儿水肿和三尖瓣反流。母亲有格雷夫斯病治疗史。婴儿在产前对母亲的治疗以及产后抗甲状腺治疗有反应,三尖瓣反流和水肿均消退。据我们所知,这是第一例与胎儿及新生儿甲状腺毒症相关的三尖瓣反流病例报告。我们的病例还强调了即使母亲的格雷夫斯病已得到治疗,获取详细准确病史的重要性。